{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:28:28Z","timestamp":1788881308715,"version":"build-2803163510"},"reference-count":30,"publisher":"Japanese Society of Internal Medicine","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2169\/internalmedicine.9194-17","type":"journal-article","created":{"date-parts":[[2017,12,14]],"date-time":"2017-12-14T22:10:35Z","timestamp":1513289435000},"page":"3379-3383","source":"Crossref","is-referenced-by-count":10,"title":["Occurrence of Dermatomyositis Immediately after Mastectomy Subsequent to Severe Chemotherapeutic Drug Eruption"],"prefix":"10.2169","volume":"56","author":[{"given":"Yuki","family":"Otsuka","sequence":"first","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"},{"name":"Okayama University Medical School, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruki","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzuki","family":"Kano","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Tatebe","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsue","family":"Sunahori-Watanabe","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Kawabata","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ei","family":"Sada","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wada","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Lakhanpal S, Bunch TW, Ilstrup DM, Melton LJ. Polymyositis-dermatomyositis and malignant lesions: does an association exist? Mayo Clin Proc 61: 645-653, 1986.","DOI":"10.1016\/S0025-6196(12)62030-8"},{"key":"2","unstructured":"2. Chen YJ, Wu CY, Huang YL, Wang CB, Shen JL, Chang YT. Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan. Arthritis Res Ther 12: R70, 2010."},{"key":"3","unstructured":"3. Fang YF, Wu YJ, Kuo CF, Luo SF, Yu KH. Malignancy in dermatomyositis and polymyositis: analysis of 192 patients. Clin Rheumatol 35: 1977-1984, 2016."},{"key":"4","unstructured":"4. Qiang JK, Kim WB, Baibergenova A, Alhusayen R. Risk of malignancy in dermatomyositis and polymyositis: a systematic review and meta-analysis. J Cutan Med Surg 21: 131-136, 2016."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Fujimoto M, Watanabe R, Ishitsuka Y, Okiyama N. Recent advances in dermatomyositis-specific autoantibodies. Curr Opin Rheumatol 28: 636-644, 2016.","DOI":"10.1097\/BOR.0000000000000329"},{"key":"6","unstructured":"6. Mockenhaupt M, Viboud C, Dunant A, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol 128: 35-44, 2008."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Halevy S, Ghislain PD, Mockenhaupt M, et al. Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel. J Am Acad Dermatol 58: 25-32, 2008.","DOI":"10.1016\/j.jaad.2007.08.036"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Roujeau JC, Kelly JP, Naldi L, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 333: 1600-1607, 1995.","DOI":"10.1056\/NEJM199512143332404"},{"key":"9","unstructured":"9. Takehara A, Aoyama Y, Kurosawa M, et al. Longitudinal analysis of antibody profiles against plakins in severe drug eruptions: emphasis on correlation with tissue damage in drug-induced hypersensitivity syndrome and drug reaction with eosinophilia and systemic symptoms. Br J Dermatol 175: 944-952, 2016."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ushigome Y, Kano Y, Ishida T, Hirahara K, Shiohara T. Short- and long-term outcomes of 34 patients with drug-induced hypersensitivity syndrome in a single institution. J Am Acad Dermatol 68: 721-728, 2013.","DOI":"10.1016\/j.jaad.2012.10.017"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Brown RJ, Rother KI, Artman H, et al. Minocycline-induced drug hypersensitivity syndrome followed by multiple autoimmune sequelae. Arch Dermatol 145: 63-66, 2009.","DOI":"10.1001\/archdermatol.2008.521"},{"key":"12","unstructured":"12. Chen YC, Chang CY, Cho YT, Chiu HC, Chu CY. Long-term sequelae of drug reaction with eosinophilia and systemic symptoms: a retrospective cohort study from Taiwan. J Am Acad Dermatol 68: 459-465, 2013."},{"key":"13","unstructured":"13. Takahashi R, Kano Y, Yamazaki Y, Kimishima M, Mizukawa Y, Shiohara T. Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome. J Immunol 182: 8071-8079, 2009."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292: 344-347, 1975.","DOI":"10.1056\/NEJM197502132920706"},{"key":"15","unstructured":"15. Zampieri S, Valente M, Adami N, et al. Polymyositis, dermatomyositis and malignancy: a further intriguing link. Autoimmun Rev 9: 449-453, 2010."},{"key":"16","unstructured":"16. Andras C, Ponyi A, Constantin T, et al. Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study. J Rheumatol 35: 438-444, 2008."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Abraham Z, Rozenbaum M, Gl\u00fcck Z, Feuerman EJ. Fulminant dermatomyositis after removal of a cancer. J Dermatol 19: 424-427, 1992.","DOI":"10.1111\/j.1346-8138.1992.tb03253.x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Racanelli V, Prete M, Minoia C, Favoino E, Perosa F. Rheumatic disorders as paraneoplastic syndromes. Autoimmun Rev 7: 352-358, 2008.","DOI":"10.1016\/j.autrev.2008.02.001"},{"key":"19","unstructured":"19. Song YJ, Wu YF, Fan T. Dermatosis as the initial manifestation of malignant breast tumors: retrospective analysis of 4 cases. Breast Care (Basel) 5: 174-176, 2010."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Nagarajan E, Rubin M, Wijdicks EFM, Hocker SE. Guillain-Barr\u00e9 syndrome after surgical procedures. Predisposing factors and outcome. Neurol Clin Pract 2017 (Epub ahead of print).","DOI":"10.1212\/CPJ.0000000000000329"},{"key":"21","unstructured":"21. Martin P, Leibovich SJ. Inflammatory cells during wound repair: the good, the bad and the ugly. Trends Cell Biol 15: 599-607, 2005."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Manson J, Thiemermann C, Brohi K. Trauma alarmins as activators of damage-induced inflammation. Br J Surg 99 (Suppl 1): 12-20, 2012.","DOI":"10.1002\/bjs.7717"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Shaw TJ, Martin P. Wound repair at a glance. J Cell Sci 122: 3209-3213, 2009.","DOI":"10.1242\/jcs.031187"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Shakhar G, Ben-Eliyahu S. Potential prophylactic measures against postoperative immunosuppression: could they reduce recurrence rates in oncological patients? Ann Surg Oncol 10: 972-992, 2003.","DOI":"10.1245\/ASO.2003.02.007"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Ishii W, Matsuda M, Shimojima Y, Itoh S, Sumida T, Ikeda S. Flow cytometric analysis of lymphocyte subpopulations and TH1\/TH2 balance in patients with polymyositis and dermatomyositis. Intern Med 47: 1593-1599, 2008.","DOI":"10.2169\/internalmedicine.47.0967"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Chen FW, Zhou X, Egbert BM, Swetter SM, Sarin KY. Dermatomyositis associated with capecitabine in the setting of malignancy. J Am Acad Dermatol 70: e47-e48, 2014.","DOI":"10.1016\/j.jaad.2013.10.025"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Akiyama C, Osada A, Sou K, et al. A case of dermatomyositis triggered by tegafur. Acta Derm Venereol 77: 490, 1997.","DOI":"10.2340\/0001555577490"},{"key":"28","unstructured":"28. Michels AW, Ostrov DA. New approaches for predicting T cell-mediated drug reactions: A role for inducible and potentially preventable autoimmunity. J Allergy Clin Immunol 136: 252-257, 2015."},{"key":"29","doi-asserted-by":"publisher","unstructured":"29. Mathews MB, Bernstein RM. Myositis autoantibody inhibits histidyl-tRNA synthetase: a model for autoimmunity. Nature 304: 177-179, 1983.","DOI":"10.1038\/304177a0"},{"key":"30","unstructured":"30. Ohta A, Yamaguchi M, Tsunematsu T, et al. Adult Still's disease: a multicenter survey of Japanese patients. J Rheumatol 17: 1058-1063, 1990."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/24\/56_9194-17\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T22:56:50Z","timestamp":1693349810000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/24\/56_9194-17\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":30,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.9194-17","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}